Display options
Share it on

Case Rep Oncol Med. 2014;2014:905478. doi: 10.1155/2014/905478. Epub 2014 Mar 04.

Clear cell adenocarcinoma of the colon: a case report and review of the literature.

Case reports in oncological medicine

Christian Daniel Barrera-Maldonado, Isidoro Wiener, Sue Sim

Affiliations

  1. Department of Graduate Medical Education, Memorial Hermann Memorial City, 921 N Gessner Road, Houston, TX 77024, USA.
  2. General and Vascular Surgery, 902 Frostwood Suite 205, Prof. Building 1, Houston, TX 77024, USA.
  3. Department of Pathology, Memorial Hermann Memorial City, 921 N Gessner Road, Houston, TX 77024, USA.

PMID: 24716050 PMCID: PMC3970243 DOI: 10.1155/2014/905478

Abstract

Clear cell adenocarcinoma of the colon has been described scarcely in the literature. It affects elderly men more commonly than women and usually appears in the left side of the colon. A Hispanic 41-year-old female came to the emergency room with abdominal pain, vomiting, and distension. Physical exam revealed generalized tenderness without peritoneal signs. Laboratory data was unremarkable. A CT scan showed an apple-core lesion in the distal colon. A flexible sigmoidoscopy revealed an obstructive mass that made further evaluation impossible. Exploratory surgery revealed a hard mass obstructing the descending colon, which was resected. Histopathology analysis with immunohistochemistry staining was positive for cytokeratin 20, cytokeratin 10, CDX2, and villin, while it was negative for cytokeratin 7, RCC, vimentin, and CD31. These results confirmed the clear cell variant of the adenocarcinoma. Clear cell adenocarcinomas usually arise from the kidneys and Müllerian organs. Immunohistochemistry is crucial for establishing the origin of these neoplastic cells. A cytokeratin 20+/7- with positive CDX2 is highly specific and sensitive for intestinal neoplastic origin. The main treatment has been surgery alone with moderately good results. More research and information about this malignancy is needed, especially in regard to prognosis and in order to provide the best treatment option.

References

  1. World J Gastroenterol. 2008 Nov 14;14(42):6575-7 - PubMed
  2. Cancer. 1964 Feb;17:259-63 - PubMed
  3. Hum Pathol. 1998 Apr;29(4):390-6 - PubMed
  4. Am J Surg Pathol. 2003 Mar;27(3):303-10 - PubMed
  5. J Clin Pathol. 2001 Jan;54(1):76-7 - PubMed
  6. Arch Pathol Lab Med. 1988 Feb;112(2):197-9 - PubMed
  7. World J Gastroenterol. 2008 Feb 21;14(7):1137-40 - PubMed
  8. Mod Pathol. 2007 Dec;20(12):1286-97 - PubMed
  9. Rare Tumors. 2010 Mar 31;2(1):e6 - PubMed
  10. Diagn Pathol. 2012 Jan 23;7:9 - PubMed
  11. J Surg Oncol. 1998 Mar;67(3):182-5 - PubMed
  12. J Clin Pathol. 1995 Dec;48(12):1142-4 - PubMed
  13. J Clin Oncol. 2011 Aug 1;29(22):e647-9 - PubMed
  14. Histopathology. 1999 Mar;34(3):250-6 - PubMed

Publication Types